Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
Advantech Europe
FLUKE BIOMEDICAL

New “Bank” Adds Genomics Service to Patient Care

By HospiMedica International staff writers
Posted on 07 Mar 2013
A new company is offering a “gene vault” service for doctors who need a better way to store, protect, and share genomic data.

Coriell Life Sciences (Camden, NJ, USA), a startup company that grew out of a partnership between the Coriell Institute for Medical Research (Camden, NJ, USA) and IBM (Armonk, NY, USA) is offering a service to facilitate sequencing a patient’s DNA—through existing sequencing companies such as Illumina (San Diego, CA, USA) or Ion Torrent—and store it in its so-called gene vault, and also act as the middleman between doctors and companies that offer interpretation services.

The cloud-based workflow could help doctors in different locations take advantage of expert interpretations anywhere, analyzing a patient’s genome for DNA variants linked to poor drug response at one point, and later on, for example, order another for variants linked to heart disease. The company will also use a board of scientific advisors to guide them as to the best interpretation programs available. Since keeping the genomic data secure is a key component of the venture, the data will be stored at IBM headquarters and would be available only to limited users. If a patient changes a health-care provider, the data will remain available for the next physician.

“The intent is that the doctor would order a test like any other diagnostic test they order today,” said Scott Megill, president of Coriell Life Sciences. “We will return the genetic result in the human readable form back to the electronic medical record so the doctor can read it and interpret it for the patient.”

“No one company is in position to interpret the entire genome for its meaning,” said Michael Christman, CEO of the Coriell Institute for Medical Research. “But by having one’s sequence in the gene vault, then the physician will be able to order interpretative engines, analogous to apps for the iPhone.”

Whole genome sequencing is a laboratory process that determines the complete DNA sequence of an organism's genome at a single time. Almost any biological sample containing a full copy of the DNA can provide the material necessary for full genome sequencing. Such samples may include saliva, epithelial cells, bone marrow, or anything else that has DNA-containing cells. Because the sequence data that is produced can be quite large (for example, there are approximately six billion base pairs in each human diploid genome), genomic data is stored electronically and requires a large amount of computing power and storage capacity.

Related Links:

Coriell Institute for Medical Research
IBM
Illumina




Channels

Critical Care

view channel
Image: The Evzio device and trainer (Photo courtesy of kaléo).

“Rescue Pen” Averts Opioid Overdose Risk

A novel autoinjector formulation of naloxone helps reduce the problem of addiction and abuse of prescription opioids. The Evzio pen is modeled on similar devices used deliver epinephrine to patients... Read more

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Business

view channel

Infusion Pumps Propel Global Market Upwards

The global infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated value of USD 7.8 billion in 2019. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company. Infusion pumps are used to deliver therapeutic... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.